Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Jun 02, 2021 10:33am
102 Views
Post# 33310351

RE:No trades

RE:No tradesRemarkable! Take a look at another Montreal based drug company, Sunshine Biopharma (SBFM). It has literally nothing at all that should attract investors who spend any time looking at it closely (pre-clinical cancer drug and nothing more than a prayer on a pre-clinical covid drug) and a disastrous balance sheet. It trades on the OTC pink sheets for $0.19 per share and has traded over 1 million shares today. It traded over 8 million shares yesterday. Clearly, we are at a nutty place with the current markets where such nonsense does go on, but zero trading for a real company versus over 1 million shares traded for a fake one is seemingly impossible, but it is not because it happened this morning.

jeffm34 wrote: Still waiting on the first trade of the day on the TSX after being open for 30 mins.  


<< Previous
Bullboard Posts
Next >>